Risk factors for severe disease and efficacy of treatment in patients infected with COVID-19: a systematic review, meta-analysis, and meta-regression analysis
Abstract The coronavirus disease 2019 (COVID-19) pandemic spread globally in the
beginning of 2020. At present, predictors of severe disease and the efficacy of different …
beginning of 2020. At present, predictors of severe disease and the efficacy of different …
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Y Jiang, T Zhao, X Zhou, Y Xiang… - MedComm, 2022 - Wiley Online Library
Abstract The 2019 coronavirus disease (COVID‐19) pandemic has become a global crisis.
In the immunopathogenesis of COVID‐19, SARS‐CoV‐2 infection induces an excessive …
In the immunopathogenesis of COVID‐19, SARS‐CoV‐2 infection induces an excessive …
Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS
C Ferrando, F Suarez-Sipmann, R Mellado-Artigas… - Intensive care …, 2020 - Springer
Purpose The main characteristics of mechanically ventilated ARDS patients affected with
COVID-19, and the adherence to lung-protective ventilation strategies are not well known …
COVID-19, and the adherence to lung-protective ventilation strategies are not well known …
[引用][C] Pathogenesis of COVID-19
AE Abaturov, EA Agafonova, EL Krivusha, AA Nikulina - 2020
Management of respiratory distress syndrome due to COVID-19 infection
JR Navas-Blanco, R Dudaryk - BMC anesthesiology, 2020 - Springer
Abstract The management of Acute Respiratory Distress Syndrome (ARDS) secondary to the
novel Coronavirus Disease 2019 (COVID-19) proves to be challenging and controversial …
novel Coronavirus Disease 2019 (COVID-19) proves to be challenging and controversial …
Acute respiratory failure in COVID-19: is it “typical” ARDS?
X Li, X Ma - Critical care, 2020 - Springer
In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) was identified in
Wuhan, China. The World Health Organization (WHO) declared this outbreak a significant …
Wuhan, China. The World Health Organization (WHO) declared this outbreak a significant …
Clinical review of COVID-19; pathogenesis, diagnosis, and management
Severe acute respiratory syndrome-coronavirus (SARS-CoV-2, or COVID-19 virus) is a
worldwide pandemic pathogen infecting 210 territories. It belongs to the family …
worldwide pandemic pathogen infecting 210 territories. It belongs to the family …
Hyperinflammatory response in COVID-19: a systematic review
MJA Silva, LR Ribeiro, MIM Gouveia, BR Marcelino… - Viruses, 2023 - mdpi.com
COVID-19 is a multisystemic disease caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). The immunopathogenic conditions of the hyperinflammatory …
coronavirus 2 (SARS-CoV-2). The immunopathogenic conditions of the hyperinflammatory …
Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19
Background Most data on the clinical presentation, diagnostics, and outcomes of patients
with COVID-19 have been presented as case series without comparison to patients with …
with COVID-19 have been presented as case series without comparison to patients with …
[HTML][HTML] Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury
C Bime, NG Casanova, J Nikolich-Zugich, KS Knox… - Translational …, 2021 - Elsevier
ABSTRACT Approximately 15%-20% of patients infected with SARS-CoV-2 coronavirus
(COVID-19) progress beyond mild and self-limited disease to require supplemental oxygen …
(COVID-19) progress beyond mild and self-limited disease to require supplemental oxygen …